Jr. Goldblum et Rj. Tuthill, CD34 AND FACTOR-XIIIA IMMUNOREACTIVITY IN DERMATOFIBROSARCOMA PROTUBERANS AND DERMATOFIBROMA, The American journal of dermatopathology, 19(2), 1997, pp. 147-153
The histologic distinction between dermatofibrosarcoma protuberans (DF
SP) and the fibrous type of benign fibrous histiocytoma (dermatofibrom
a, DF) may be extremely difficult. in this study, we evaluated the ext
ent and pattern of immunoreactivity of both CD34 and factor XIIIa in a
large number of DFSPs and DFs in order to determine the utility of th
ese markers in their distinction. Using histologic criteria alone, the
authors independently evaluated and agreed upon 30 cases of DF and 24
cases of DFSP, and a representative section was stained with antibodi
es to both factor XIIIa and CD34. Immunopositivity was evaluated semiq
uantitatively and assigned a score from 0 to 5. CD34 immunoreactivity
was seen in 22 (92%) of 24 DFSPs (mean CD34 score, 4.60 +/- 0.3). Only
12 (40%) of 30 DFs showed CD34 immunopositivity (mean CD34 score, 0.6
+/- 0.1). Factor XIIIa was seen in 29 (97%) of 30 DFs (mean factor-XI
IIa score, 4.1 +/- 0.3). In contrast, 18 (75%) of 24 DFSPs stained for
factor XIIIa (mean factor-XIIIa score, 1.3 +/- 0.2), but in most of t
hese cases the factor-XIIIa-positive cells were felt to be entrapped n
onneoplastic dermal dendrocytes. Thus, an immunoprofile using antibodi
es to CD34 and factor XIIIa is capable of distinguishing between DFSP
and the fibrous type of DF in the vast majority of cases, as long as t
here is recognition that there may be some CD34-positive cells in DFs,
as well as some factor-XIIIa-positive cells in DFSPs.